Chinese Covid-Vaccine Maker Clover Biopharma Set for Hong Kong Debut

China’s Clover Biopharmaceuticals is set to debut on the Stock Exchange of Hong Kong on Friday as it races to win regulatory approval and begin shipments of its Covid-19 vaccine. Though founded in …
( read original story …)

---